Composition for Treating Spermatogenesis and Semen Disorders / FPT-20
Status:
Completed
Trial end date:
2022-05-20
Target enrollment:
Participant gender:
Summary
Research to develop a new, natural-derived formulation that eliminates inflammatory tissue
and regenerates new tissue of the lobules, epithelium of the tubules, and connective tissue
surrounding the seminiferous tubules in the testes. It restores Leydig cells and Sertoli
cells' function (because the inflamed testicles were unable to perform spermatogenesis).